Quinones as neuroprotective agents

Á Cores, N Carmona-Zafra, J Clerigué, M Villacampa… - Antioxidants, 2023 - mdpi.com
Quinones can in principle be viewed as a double-edged sword in the treatment of
neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic …

Heat shock proteins in neurodegenerative disorders and aging

RK Leak - Journal of cell communication and signaling, 2014 - Springer
Many members of the heat shock protein family act in unison to refold or degrade misfolded
proteins. Some heat shock proteins also directly interfere with apoptosis. These homeostatic …

Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

S Paul, S Mahanta - Molecular and cellular biochemistry, 2014 - Springer
A number of acute and chronic neurodegenerative disorders are caused due to misfolding
and aggregation of many intra-and extracellular proteins. Protein misfolding and …

Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease

A Benedetto, C Au, M Aschner - Chemical reviews, 2009 - ACS Publications
Manganese (Mn) is an abundant, naturally occurring element in the Earth's crust. It is most
frequently found in the form of oxides, carbonates, and silicates. 1 It is also one out of seven …

Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson's disease

R Gonzalez, I Garitaonandia… - Cell …, 2016 - journals.sagepub.com
Cell therapy has attracted considerable interest as a promising therapeutic alternative for
patients with Parkinson's disease (PD). Clinical studies have shown that grafted fetal neural …

To fold or not to fold: modulation and consequences of Hsp90 inhibition

LB Peterson, BSJ Blagg - Future medicinal chemistry, 2009 - Taylor & Francis
Background: The 90-kDa heat-shock proteins (Hsp90) have rapidly evolved into promising
therapeutic targets for the treatment of several diseases, including cancer and …

Native MS: an 'ESI'way to support structure-and fragment-based drug discovery

V Vivat Hannah, C Atmanene, D Zeyer… - Future medicinal …, 2010 - Taylor & Francis
The success of early drug-discovery programs depends on the adequate combination of
complementary and orthogonal technologies allowing hit/lead compounds to be optimized …

LRRK2 and neurodegeneration

G Santpere, I Ferrer - Acta neuropathologica, 2009 - Springer
Mutations in leucine-rich repeat kinase 2 gene (PARK8/LRRK2) encoding the protein Lrrk2
are causative of inherited and sporadic Parkinson's disease (PD) with phenotypic …

LRRK2 in Parkinson's disease: biochemical functions

VS Anand, SP Braithwaite - The FEBS journal, 2009 - Wiley Online Library
Leucine‐rich repeat kinase 2 (LRRK2) is a large, complex, multidomain protein containing
kinase and GTPase enzymatic activities and multiple protein–protein interaction domains …

A novel Hsp90 inhibitor activates compensatory heat shock protein responses and autophagy and alleviates mutant A53T α-synuclein toxicity

R Xiong, W Zhou, D Siegel, RRA Kitson, CR Freed… - Molecular …, 2015 - ASPET
A potential cause of neurodegenerative diseases, including Parkinson's disease (PD), is
protein misfolding and aggregation that in turn leads to neurotoxicity. Targeting Hsp90 is an …